News Quantified

KURA – kura oncology, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ARDX, TNDM and VIAV are among after hour movers [Seeking Alpha]

Kura Oncology Reports First Quarter 2024 Financial Results [Yahoo! Finance]

0.2%

MISS

-1.7%

BEAT

7.0%

BEAT

3.8%

BEAT

Form SC 13G Kura Oncology, Inc. Filed by: Paradigm Biocapital Advisors LP

Form 10-Q Kura Oncology, Inc. For: Mar 31

Form 8-K Kura Oncology, Inc. For: May 02

Form ARS Kura Oncology, Inc. For: Dec 31

Form DEF 14A Kura Oncology, Inc. For: Apr 12

Top News Gainers

4/28 Kura Oncology Inc (NASDAQ: KURA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. 41.3%

5/7 Q1/2019 3/31/2019 EPS -0.370 ZacksConsensus -0.450 ActVsEst 0.080 - Beat 9.6%

5/24 Kura Oncology Inc (NASDAQ: KURA) had its price target raised by analysts at Citigroup Inc from $18.00 to $25.00. They now have a "buy" rating on the stock. 8.3%

4/9 Kura Oncology Inc (NASDAQ: KURA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. 7.9%

3/19 Kura Oncology Inc (NASDAQ: KURA) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 7.4%

6/18 Form 424B5 Kura Oncology, Inc. 7.1%

9/5 Kura Oncology Inc (NASDAQ: KURA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. 5.9%

10/15 Kura Oncology Expands Board of Directors with Appointment of Diane Parks 4.9%

6/17 Kura Oncology Inc (NASDAQ: KURA) had its "positive" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock, up previously from $23.00. 4.6%

2/29 Kura Oncology Inc (NASDAQ: KURA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. 4.1%

Top News Decliners

3/17 Kura Oncology (KURA) Presents At Cowen and Compnay Health Care Conference - Slideshow [Seeking Alpha] -14.5%

3/11 Kura Oncology Inc (NASDAQ: KURA) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -7.8%

6/14 Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal [MarketWatch] -5.0%

8/2 Kura Oncology, Inc. 2019 Q2 - Results - Earnings Call Slides [Seeking Alpha] -4.8%

7/18 Kura Oncology Inc (NASDAQ: KURA) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $28.00 price target on the stock. -4.5%

8/21 Form S-3/A Kura Oncology, Inc. -4.4%

3/4 Form 8-K Kura Oncology, Inc. For: Mar 03 -4.3%

8/21 Kura Oncology Inc (NASDAQ: KURA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.0%

3/17 Form CT ORDER Kura Oncology, Inc. -3.9%

1/23 Kura Oncology Announces Transition of Chief Medical Officer -3.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day